Post by
Noteable on Dec 20, 2022 4:29pm
FDA seeks Accelerated Approval reform in Spending Bill
As posted earlier today regarding the FDA's accelerated approval reforms sought in the current Congressional Spending Bill and Big Pharma's enhanced interest in ONCY's pre-emptive approach in postitioning pelarerorep for an accelerated approval....
" ONCY is ready for the FDA's recently sought reforms in the accelerated approval process that would be be codified in the new Congressional Spending Bill as a result of ONCY's clinical trial progress and stated intent towards the filing of a registrational breast cancer study."